KRAS and colorectal cancer: Oncogenic KRAS driver mutations in lung and colorectal cancers (8, 9) are thought to play a key role in driving neutrophil phenotype within tumors, with clear upregulation of neutrophil chemotactic protein production from metastatic lesions (10).